Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

CP and cardiomyopathy are reported together in 1 article.

Gene

CP

HGNC
HGNC:2295
20articles
20mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
HPO
HP:0001638
618articles
618mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.

PMID 20299794 | DOI 10.1159/000298822 · Chemotherapy · 2010 · 2 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneCP“BACKGROUND: This study examined, for the first time, the involvement of carnitine deficiency in cardiotoxicity, particularly cyclophosphamide (CP)-induced cardiomyopathy, as well as effects of carnitine supplementation with propionyl-L-carnitine (PLC) on cardiotoxicity.”0.98hgnc_dict_v1
phenotypecardiomyopathy“BACKGROUND: This study examined, for the first time, the involvement of carnitine deficiency in cardiotoxicity, particularly cyclophosphamide (CP)-induced cardiomyopathy, as well as effects of carnitine supplementation with propionyl-L-carnitine (PLC) on cardiotoxicity.”0.98phenotype_alias_lexicon_v2